Live Breaking News & Updates on தேசிய ப்ரையாரிடீ ஆராய்ச்சி|Page 1

Stay updated with breaking news from தேசிய ப்ரையாரிடீ ஆராய்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Inotrem's COVID-19 Phase IIa Clinical Trial Declared "National Priority Research" by the French Government's Clinical Trial Council


Press release content from Business Wire. The AP news staff was not involved in its creation.
Inotrem’s COVID-19 Phase IIa Clinical Trial Declared “National Priority Research” by the French Government’s Clinical Trial Council
December 24, 2020 GMT
PARIS (BUSINESS WIRE) Dec 24, 2020
Inotrem S.A., a biotechnology company specialized in the development of immunotherapies targeting the TREM-1 pathway, announces today that its Phase IIa study of nangibotide, the company’s lead product, for the treatment of severe forms of COVID-19 has been declared “National Priority Research” by the French government steering committee for therapeutic clinical trials and other research (CAPNET). ....

United States , Jean Jacques Garaud , Research National Priority , National Priority Research , Roche Group , Scientific Council , French Ethics Committee , Jacques Garaud , North American , Business Wire , Products And Services , Coronavirus Pandemic , Product Testing , Health Care Industry , Lung Disease , Medical Biotechnology Industry , Medical Research , Clinical Trials , Western Europe , Infectious Diseases , Corporate News , North America , Diseases And Conditions , Government And Politics , ஒன்றுபட்டது மாநிலங்களில் , ஜீன் ஜாக்ஸ் காரௌத் ,